ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,285.71
1.21%
Dow Jones
40,589.34
1.64%
Gold vs US Dollar
2,387.035
0.00%
Brent Oil
79.745
0.00%
Bitcoin
68,431.77
0.76%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Bone Biologics Corporation (BBLG)

  7. Bone Biologics Corporation (BBLG) News

Bone Biologics (BBLG)

Bone Biologics Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:BBLG
DateTimeSourceHeadlineSymbolCompany
21/06/202413:35GlobeNewswire Inc.Life Science Virtual Investor Forum Presentations Now Available for Online ViewingNASDAQ:BBLGBone Biologics Corporation
06/03/202421:15Business WireBone Biologics Announces Closing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
05/03/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
04/03/202422:21Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:BBLGBone Biologics Corporation
04/03/202414:15Business WireBone Biologics Announces Pricing of $2.0 Million Public OfferingNASDAQ:BBLGBone Biologics Corporation
01/03/202413:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
01/03/202413:00Business WireBone Biologics Reports Progress With NB1 Clinical ProgramNASDAQ:BBLGBone Biologics Corporation
26/02/202421:50Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
23/02/202422:09Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
21/02/202422:05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:BBLGBone Biologics Corporation
14/02/202423:41Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
14/02/202415:55Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
14/02/202401:03Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
30/01/202422:09Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
25/01/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:BBLGBone Biologics Corporation
19/01/202422:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
19/01/202422:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
17/01/202422:21Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:BBLGBone Biologics Corporation
12/01/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
11/01/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
11/01/202413:00Business WireBone Biologics Appoints Healthcare Finance Veteran Robert E. Gagnon to Board of DirectorsNASDAQ:BBLGBone Biologics Corporation
10/01/202422:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
10/01/202422:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:BBLGBone Biologics Corporation
10/01/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
10/01/202413:00Business WireBone Biologics Regains Compliance with Nasdaq Continued Listing RequirementsNASDAQ:BBLGBone Biologics Corporation
05/01/202422:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:BBLGBone Biologics Corporation
02/01/202422:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
02/01/202420:34Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
20/12/202322:21Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:BBLGBone Biologics Corporation
18/12/202313:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:BBLGBone Biologics Corporation
 Showing the most relevant articles for your search:NASDAQ:BBLG

Your Recent History

LSE
VAST
Vast Resources
LSE
SBTX
Skinbiotherapeutics
LSE
SCLP
Scancell
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
UKOG
Uk Oil & Gas
LSE
PPP
Pennpetro Energy
LSE
EDEN
Eden Research
LSE
BOO
Boohoo
LSE
QBT
Quantum Blockchain Techn...
LSE
HUM
Hummingbird Resources
LSE
ALBA
Alba Mineral Resources
LSE
POS
Plexus
LSE
BP.
Bp
LSE
ASC
Asos
LSE
TERN
Tern
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved